Replies to post #21636 on Intellicell Biosciences Inc (fka SVFC)

[cjstocksup]

SVFC Intellicell Biosciences Inc validated by Merck!!!

IntelliCell's stem cell technology validated by Merck study
by Deborah Sterescu IntelliCell BioSciences (OTCQB:SVFC) said Thursday that its technology used to generate fat, or adipose, stem cells was tested by a division of healthcare giant Merck, with positive results.
Fat stem cells are now the cutting edge, with many doctors and companies researching the use of them for the treatment of arthritis, as well as a host of orthpedic injuries, and congestive heart failure, gum recession, wound healing, along with a several other ailments.
IntelliCell has developed an in-house technology where it can process stromal vascular fraction (SVF) cells containing a high concentration of adipose stem cells. The company believes that it is currently the only one that does not use enzymes in processing adipose tissue, and actually counts and checks the adipose stem cells they manufacture.
The company's technique takes approximately 30 minutes, and the stem cells can be returned to the doctor in the same day.
Millipore, owned by Merck, performed an antibody flow cytometry study of IntelliCell's technology, which showed that the company's manufactured cells yielded an average of 10 times the number of SVF cells containing adult adipose stem cells, from less fat than that which the IntelliCell believes is used by an of its competition using enzymes in their process.
The study also showed that IntelliCell's cells contain all of the viable cells that are manufactured by competing technologies.
"We believe IntelliCell is setting the gold standard for adipose stem cell processing without the use of enzymes and yielding high number of SVFs with adult adipose stem cell counts," said IntelliCell chairman and CEO, Dr. Steven Victor.
"We feel that our technology is a true game changer in the field of regenerative medicine and that SVF could show incredible promise for a wide range of clinical uses in the near future.
"We believe that the body stores all of the reparative and regenerative cells it could possibly need as a result of trauma or illness in the stromal vascular fraction (SVF) contained in the fat."
Indeed, these fat stem cells have similar potential to embryonic stem cells in their pluripotency, in vast number, from a source that involves no moral or ethical issues, as well as no chemical additives required for digestion of the tissue.
In the aesthetic world, the use of autologous adipose stem cells has become widely accepted in Europe and Asia. Since the US FDA published its laws on autologous stem cells in mid-2009, the field has expanded rapidly.
IntelliCell has established processing centers in New York City, Philadelphia, Dallas/Ft. Worth, and New Orleans, and has entered into a licensing agreement for a center in Palm Beach.